Nautilus Biotechnology, Inc. (NAUT) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 46 transactions totaling $60.0M, demonstrating a bullish sentiment with $59.5M in net insider flow. The most recent transaction on Nov 6, 2025 involved a purchase of 4,000 shares valued at $6.0K.
No significant insider buying has been recorded for NAUT in the recent period.
No significant insider selling has been recorded for NAUT in the recent period.
Based on recent SEC filings, insider sentiment for NAUT is bullish with an Insider Alignment Score of 100/100 and a net flow of $59.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Nautilus Biotechnology, Inc. (NAUT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading NAUT stock, having executed 46 transactions in the past 90 days. The most active insider is Life Sciences Master Fund Ltd Perceptive (Executive), who has made 4 transactions totaling $56.1M.
Get notified when executives and directors at NAUT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 6, 2025 | Suzuki Kentaro | Executive | Purchase | 4,000 | $1.49 | $6.0K | |
| Sep 8, 2025 | M. Patel Sujal | Executive | Purchase | 83,500 | $0.68 | $56.8K | |
| Sep 5, 2025 | M. Patel Sujal | Executive | Purchase | 116,500 | $0.67 | $78.1K | |
| Sep 4, 2025 | B. Murphy Matthew | Executive | Purchase | 20,000 | $0.64 | $12.8K | |
| Sep 23, 2024 | E. Godwin Mary | Executive | Sale | 47,031 | $2.87 | $135.0K | |
| Sep 23, 2024 | E. Godwin Mary | Executive | Option Exercise | 47,031 | $0.46 | $21.6K | |
| Sep 17, 2024 | E. Godwin Mary | Executive | Option Exercise | 35,000 | $0.46 | $16.1K | |
| Sep 17, 2024 | E. Godwin Mary | Executive | Sale | 35,000 | $2.85 | $99.8K | |
| Mar 11, 2024 | M. Patel Sujal | Executive | Purchase | 12,044 | $2.84 | $34.2K | |
| Mar 8, 2024 | M. Patel Sujal | Executive | Purchase | 2,430 | $2.99 | $7.3K | |
| Mar 7, 2024 | M. Patel Sujal | Executive | Purchase | 18,854 | $2.89 | $54.5K | |
| Mar 6, 2024 | M. Patel Sujal | Executive | Purchase | 9,267 | $2.70 | $25.0K | |
| Mar 5, 2024 | M. Patel Sujal | Executive | Purchase | 7,405 | $2.65 | $19.6K | |
| Sep 27, 2022 | Sankar Subramanian | Executive | Purchase | 5,000 | $2.03 | $10.2K | |
| Sep 26, 2022 | Sankar Subramanian | Executive | Purchase | 10,000 | $2.03 | $20.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 38 | $59.8M | 99.5% |
Sale(S) | 2 | $234.7K | 0.4% |
Exercise(M) | 3 | $38.7K | 0.1% |
Award(A) | 1 | $32.8K | 0.1% |
Gift(G) | 1 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insiders at Nautilus Biotechnology, Inc. are accumulating shares at an accelerated pace. With 11 insiders making 46 transactions totaling $59.8M in purchases versus $234.7K in sales, the net buying activity of $59.5M signals strong executive confidence. Life Sciences Master Fund Ltd Perceptive (Executive) leads the buying activity with $56.1M in transactions across all time.